Astaxanthin has been shown to be beneficial therapy in diabetic retinopathy and neuropathy by activating the NF-κB pathway, suppressing microvascular injuries by VEGF generation, and anti-apoptotic activity via modulation of MAPKs and PI3K/Akt pathways [49]. The gene discussed is VEGFA; the disease is diabetic retinopathy.